Linagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 72205-409

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Linagliptin And Metformin Hydrochloride (NDC 72205-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lina-met-tabs--figure-1 (Lina Met Tabs Figure 1)

FDA Label Image

Lina-met-tabs--figure-3 (Lina Met Tabs Figure 3)

FDA Label Image

Lina-met-tabs-2-5mg-1000mg-180s-count (Lina Met Tabs 2 5mg 1000mg 180s Count)

This text contains information about a medication called Linagliptin and Metformin Hydrochloride Tablets, with a dosage of 2.5 mg of linagliptin and 1,000 mg of metformin hydrochloride per tablet. The recommended dosage and storage instructions are provided, along with details about the manufacturer and distributor. The medication guide should be dispensed with each prescription.*

FDA Label Image

Lina-met-tabs-2-5mg-1000mg-60s-count (Lina Met Tabs 2 5mg 1000mg 60s Count)

Each tablet contains 2.5 mg of linagliptin and 1,000 mg of metformin hydrochloride. The medication is manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ. It is recommended to store at 20°C to 25°C (68°F to 77°F) and protect from exposure to high humidity. The recommended dosage is mentioned in the Prescribing Information provided with the medication.*

FDA Label Image

Lina-met-tabs-2-5mg-500mg-180s-count (Lina Met Tabs 2 5mg 500mg 180s Count)

This is a prescription medication in tablet form containing 2.5 mg of linagliptin and 500 mg of metformin hydrochloride. It is used to treat certain conditions as indicated in the prescribing information. The medication is to be stored at room temperature and protected from high humidity. It is advised to dispense the accompanying Medication Guide to each patient. The product is distributed by Novadoz Pharmaceuticals LLC.*

FDA Label Image

Lina-met-tabs-2-5mg-500mg-60s-count (Lina Met Tabs 2 5mg 500mg 60s Count)

This text provides information about a prescription medication with NDC 72205-407-01, containing 2.5 mg of linagliptin and 500 mg of metformin hydrochloride per tablet. It offers guidance on recommended dosage, storage conditions, and precautions such as temperature control and protection from humidity. The medication is distributed by Novadoz Pharmaceuticals LLC.*

FDA Label Image

Lina-met-tabs-2-5mg-850mg-180s-count (Lina Met Tabs 2 5mg 850mg 180s Count)

This text is a prescription information for Linagliptin and Metformin Hydrochloride Tablets, containing 2.5 mg of linagliptin and 850 mg of metformin hydrochloride per tablet. It provides guidance for pharmacists to dispense the Medication Guide to each patient, recommends storing the tablets at 20°C to 25°C, and indicates the manufacturer as MSN Laboratories Private Limited in India. The recommended dosage is not provided, and it instructs to keep the tablets out of reach of children. The distributed by Novadoz Pharmaceuticals LLC located in Piscataway, NJ.*

FDA Label Image

Lina-met-tabs-2-5mg-850mg-60s-count (Lina Met Tabs 2 5mg 850mg 60s Count)

This is a prescription medication containing 2.5 mg of linagliptin and 850 mg of metformin hydrochloride. Each tablet is equivalent to 662.88 mg of metformin. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It should be protected from exposure to high humidity and kept out of reach of children. The medication guide should be dispensed to each patient. This product is manufactured by MSN Laboratories Private Limited in Telangana, India, and distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ.*

FDA Label Image

Lina-met-tabs-figure-2 (Lina Met Tabs Figure 2)

This is a table showing the number of patients at risk in a clinical trial for a comparison between placebo and linagliptin treatment groups over a certain period of time in years. The numbers in each column represent the patients at risk at different time points, indicating the progression of the study.*

FDA Label Image

Lina-met-tabs-structure1 (Lina Met Tabs Structure1)

FDA Label Image

Lina-met-tabs-structure2 (Lina Met Tabs Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.